** Shares of Integra LifeSciences IART.O fall 4.8% to $21 premarket
** Life sciences firm posts Q4 revenue of $442.6 million, missing analyst est of $445.1 million, as per data compiled by LSEG
** Co reports Q4 adj profit of 97 cents/share vs analyst est of 86 cents/share
** IART forecasts 2025 revenue in the range of $1.65 bln to $1.71 bln
** Analysts, on average, were expecting revenue to be $1.71 bln for 2025
** Co says it expects Q1 revenue in the range of $375 mln to $385 mln, lower than analyst est. of $410.2 mln
** IART forecasts Q1 profit in the range of $0.40/share to $0.45/share
** Stock has fallen 50.7% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。